Systemic bevacizumab leads to resolution of diabetic macular edema.

Published

Journal Article

PURPOSE: The purpose of this study is to report a case of diabetic macular edema that resolved after systemic bevacizumab. METHODS: This is an observational case report of a patient with diabetic macular edema. RESULTS: After initiation of systemic bevacizumab for a central nervous system glioblastoma, the diabetic macular edema resolved. CONCLUSION: Systemic bevacizumab may result in the resolution of macular edema secondary to diabetes.

Full Text

Duke Authors

Cited Authors

  • Ehlers, JP; Fekrat, S

Published Date

  • January 2010

Published In

Volume / Issue

  • 4 / 4

Start / End Page

  • 297 - 299

PubMed ID

  • 25390902

Pubmed Central ID

  • 25390902

Electronic International Standard Serial Number (EISSN)

  • 1937-1578

International Standard Serial Number (ISSN)

  • 1935-1089

Digital Object Identifier (DOI)

  • 10.1097/icb.0b013e3181b86238

Language

  • eng